Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
MIRA Pharmaceuticals, Inc. ( (MIRA) ) has shared an announcement.
On September 11, 2025, MIRA Pharmaceuticals, Inc. held its Annual Meeting of Shareholders where the 2022 Omnibus Incentive Plan was approved. This plan increases the number of shares reserved from 5,000,000 to 8,000,000 and allows for the repricing of options or stock appreciation rights, potentially impacting the company’s financial strategies and shareholder value.
The most recent analyst rating on (MIRA) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on MIRA Pharmaceuticals, Inc. stock, see the MIRA Stock Forecast page.
More about MIRA Pharmaceuticals, Inc.
Average Trading Volume: 1,328,501
Technical Sentiment Signal: Strong Buy
For an in-depth examination of MIRA stock, go to TipRanks’ Overview page.